{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:41:24Z","timestamp":1760463684944,"version":"build-2065373602"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Individuals with end-stage renal disease have a considerably higher rate of malignant tumors, especially renal cancer, in comparison to the general population. However, cases in which bone metastases in the humerus are the initial clinical presentation that results in a diagnosis of renal cancer are extremely rare. Diagnosing renal cancer in patients with end-stage renal disease can be challenging when the clinical symptoms are atypical and do not present the \u201crenal cancer triad.\u201d Our case report highlights the diagnostic importance of positron emission tomography\/computed tomography (CT) imaging, increases clinicians\u2019 awareness of the disease, explores the potential etiology of renal cancer associated with end-stage renal disease, and provides insights into diagnostic and therapeutic strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 58-year-old man, who has undergone multiple renal transplants and maintenance dialysis therapy for over 20 years due to renal failure, arrived at our hospital with complaints of left shoulder pain and progressive worsening. CT revealed unexplained osteolytic destruction and fracture in the left humerus. The <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose positron emission tomography\/CT scan detected soft tissue lesions in the left kidney and exhibited increased fluorodeoxyglucose uptake.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Upon conducting a biopsy on the patient\u2019s left humerus, metastatic renal cancer was diagnosed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient selected conservative treatment, and the injured humerus was immobilized to stabilize the affected area. There was no additional active treatment for renal cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>As of the time of submission, the patient\u2019s pain had markedly intensified, requiring oral pain medication for symptomatic relief.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>It is indeed rare for bone metastasis in the humerus to be the initial clinical sign that leads to the diagnosis of renal cancer in patients with end-stage renal disease. Through this case report, we aimed to enhance awareness and deepen understanding of renal cancer associated with end-stage renal disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043595","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T10:00:15Z","timestamp":1753956015000},"page":"e43595","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT identifies isolated metastasis of renal cancer in a patient with end-stage renal disease: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6319-0242","authenticated-orcid":false,"given":"Chongling","family":"Duan","sequence":"first","affiliation":[{"name":"Department of PET\/CT, Jining NO.1 People\u2019s Hospital, Shandong First Medical University, Jining, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7624-2822","authenticated-orcid":false,"given":"Lin","family":"An","sequence":"additional","affiliation":[{"name":"Department of PET\/CT, Jining NO.1 People\u2019s Hospital, Shandong First Medical University, Jining, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy.","volume":"52","author":"Thurlow","year":"2021","journal-title":"Am J Nephrol"},{"key":"R2-20251014","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009.","volume":"65","author":"Butler","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R3-20251014","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/cancers14061595","article-title":"The role of surgery in spinal intradural metastases from renal cell carcinoma: a literature review.","volume":"14","author":"Corvino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R4-20251014","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.eururo.2011.02.035","article-title":"Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.","volume":"60","author":"Neuzillet","year":"2011","journal-title":"Eur Urol"},{"key":"R5-20251014","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.eururo.2022.01.040","article-title":"Novel imaging methods for renal mass characterization: a collaborative review.","volume":"81","author":"Roussel","year":"2022","journal-title":"Eur Urol"},{"key":"R6-20251014","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1681\/ASN.2014040376","article-title":"CKD and risk of renal cell carcinoma: a causal association?","volume":"25","author":"Hofmann","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R7-20251014","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jcp.30.9.868","article-title":"Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis.","volume":"30","author":"Dunnill","year":"1977","journal-title":"J Clin Pathol"},{"key":"R8-20251014","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0033-8389(22)00680-7","article-title":"Acquired cystic kidney disease.","volume":"34","author":"Levine","year":"1996","journal-title":"Radiol Clin North Am"},{"key":"R9-20251014","first-page":"592","article-title":"Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis.","volume":"110","author":"Hughson","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20251014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-6143.2010.03376.x","article-title":"Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients.","volume":"11","author":"Shapiro","year":"2011","journal-title":"Am J Transplant"},{"key":"R11-20251014","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","article-title":"The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia.","volume":"37","author":"Srigley","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R12-20251014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/164_2021_554","article-title":"Malignancy: an adverse effect of immunosuppression.","volume":"272","author":"Munagala","year":"2022","journal-title":"Handb Exp Pharmacol"},{"key":"R13-20251014","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000002626","article-title":"Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: an analysis from the randomized TRANSFORM Study.","volume":"103","author":"Tedesco-Silva","year":"2019","journal-title":"Transplantation"},{"key":"R14-20251014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000001447","article-title":"Cancer and mTOR inhibitors in transplant recipients.","volume":"101","author":"de Fijter","year":"2017","journal-title":"Transplantation"},{"key":"R15-20251014","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3390\/biomedicines10030657","article-title":"Renal cell carcinoma in end-stage renal disease: a review and update.","volume":"10","author":"El-Zaatari","year":"2022","journal-title":"Biomedicines"},{"key":"R16-20251014","first-page":"737","article-title":"Cancer screening in end-stage renal disease.","volume":"20","author":"Rao","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R17-20251014","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s11604-024-01593-5","article-title":"Efficacy of (18)F-Fluorodeoxyglucose positron emission tomography\/computed tomography for detecting renal cell carcinoma in patients with end-stage renal disease.","volume":"42","author":"Hirasawa","year":"2024","journal-title":"Jpn J Radiol"},{"key":"R18-20251014","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s00261-022-03566-6","article-title":"Acquired cystic disease subtype renal cell carcinoma (ACD-RCC): prevalence and imaging features at a single institution.","volume":"47","author":"Carnahan","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"R19-20251014","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10157-010-0347-3","article-title":"Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.","volume":"15","author":"Ishikawa","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"R20-20251014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11604-018-0789-1","article-title":"Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison (11)C-choline and FDG PET\/CT with dynamic contrast-enhanced CT.","volume":"37","author":"Kitajima","year":"2019","journal-title":"Jpn J Radiol"},{"key":"R21-20251014","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3390\/biomedicines9121761","article-title":"Kidney cancer and chronic kidney disease: too close for comfort.","volume":"9","author":"Pinto","year":"2021","journal-title":"Biomedicines"},{"key":"R22-20251014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10585-011-9379-7","article-title":"Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis.","volume":"28","author":"Yuasa","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"R23-20251014","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2008.19.2146","article-title":"Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.","volume":"27","author":"Fizazi","year":"2009","journal-title":"J Clin Oncol"},{"key":"R24-20251014","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update.","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"R25-20251014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/sdi.12888","article-title":"Outcome of renal cell carcinoma in patients on dialysis compared to non-dialysis patients.","volume":"33","author":"Hayami","year":"2020","journal-title":"Semin Dial"},{"key":"R26-20251014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cancers16010003","article-title":"Renal cell carcinoma in end-stage kidney disease and the role of transplantation.","volume":"16","author":"Robinson","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:01:40Z","timestamp":1760461300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":26,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043595","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}